Pages that link to "Q39685110"

The following pages link to The genetic basis of resistance to 5-fluorocytosine in Candida species and Cryptococcus neoformans (Q39685110):

Displaying 26 items.

• Antifungal resistance in pathogenic fungi (Q28208165) (← links)
• Antifungal Therapy: New Advances in the Understanding and Treatment of Mycosis (Q28818603) (← links)
• A diverse population of Cryptococcus gattii molecular type VGIII in southern Californian HIV/AIDS patients (Q30406964) (← links)
• Clinical, cellular, and molecular factors that contribute to antifungal drug resistance. (Q33721804) (← links)
• Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance (Q33749111) (← links)
• Cryptococcus neoformans resistance to echinocandins: (1,3)beta-glucan synthase activity is sensitive to echinocandins (Q33883762) (← links)
• Canadian Clinical Practice Guidelines for Invasive Candidiasis in Adults (Q34237335) (← links)
• Antifungal resistance among Candida species (Q34335225) (← links)
• Antifungal drug resistance of pathogenic fungi. (Q34863076) (← links)
• Mechanisms of fungal resistance: an overview (Q34621454) (← links)
• Microbial and viral drug resistance mechanisms (Q34960279) (← links)
• Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies (Q35512289) (← links)
• A flucytosine-responsive Mbp1/Swi4-like protein, Mbs1, plays pleiotropic roles in antifungal drug resistance, stress response, and virulence of Cryptococcus neoformans (Q35666161) (← links)
• Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. (Q36018713) (← links)
• Noninvasive quantitation of cytosine deaminase transgene expression in human tumor xenografts with in vivo magnetic resonance spectroscopy (Q36436012) (← links)
• The fungal resistome: a risk and an opportunity for the development of novel antifungal therapies (Q38835045) (← links)
• The presence of an R467K amino acid substitution and loss of allelic variation correlate with an azole-resistant lanosterol 14alpha demethylase in Candida albicans (Q39784510) (← links)
• Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches (Q40878512) (← links)
• Nonsense and missense mutations in FCY2 and FCY1 genes are responsible for flucytosine resistance and flucytosine-fluconazole cross-resistance in clinical isolates of Candida lusitaniae. (Q42183289) (← links)
• Mutational Analysis of Flucytosine Resistance in Candida glabrata (Q42376066) (← links)
• Global transcriptional profiles of Trichophyton rubrum in response to Flucytosine (Q43217794) (← links)
• Allelic variation in the contiguous loci encoding Candida albicans ALS5, ALS1 and ALS9 (Q47590306) (← links)
• The mechanistic basis of pH-dependent 5-flucytosine resistance in Aspergillus fumigatus. (Q52334121) (← links)
• Antifungal Susceptibility Testing of Candida and Cryptococcus Species and Mechanisms of Resistance: Implications for Clinical Laboratories (Q57745988) (← links)
• Multiplex Genetic Engineering Exploiting Pyrimidine Salvage Pathway-Based Endogenous Counterselectable Markers (Q91707611) (← links)
• 5-fluorocytosine resistance is associated with hypermutation and alterations in capsule biosynthesis in Cryptococcus (Q92491341) (← links)